2,206
Views
0
CrossRef citations to date
0
Altmetric
Neurology

Myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia are indistinguishable by their cerebrospinal fluid proteomes

, , , , , , , , & show all
Article: 2208372 | Received 11 Dec 2022, Accepted 24 Apr 2023, Published online: 18 Sep 2023

References

  • Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(9182):1–7.
  • Cook DB, Stegner AJ, Nagelkirk PR, et al. Responses to exercise differ for chronic fatigue syndrome patients with fibromyalgia. Med Sci Sports Exerc. 2012;44(6):1186–1193.
  • Kishi A, Natelson BH, Togo F, et al. Sleep-stage dynamics in patients with chronic fatigue syndrome with or without fibromyalgia. Sleep. 2011;34(11):1551–1560.
  • Schutzer SE. Rapidly maturing field of proteomics: a gateway to studying diseases. Proteomics. 2014;14(9):991–993.
  • Smith RD. Mass spectrometry in biomarker applications: from untargeted discovery to targeted verification, and implications for platform convergence and clinical application. Clin Chem. 2012;58(3):528–530.
  • Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics. 2014;13(3):907–917.
  • Schutzer SE, Angel TE, Liu T, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One. 2011;6(2):e17287.
  • Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121(12):953–959.
  • Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33(2):160–172.
  • Shi T, Fillmore TL, Sun X, et al. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proc Natl Acad Sci U S A. 2012;109(38):15395–15400.
  • Qian WJ, Liu T, Monroe ME, et al. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. J Proteome Res. 2005;4(1):53–62.
  • Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4(3):207–214.
  • Jason LA, Richman JA, Rademaker AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med. 1999;159(18):2129–2137.
  • Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130(11):910–921.
  • Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37(11):1593–1601.
  • Evengård B, Nilsson CG, Lindh G, et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain. 1998;78(2):153–155.
  • Abbi B, Natelson BH. Is chronic fatigue syndrome the same illness as fibromyalgia: evaluating the ‘single syndrome’ hypothesis. QJM. 2013;106(1):3–9.
  • Cook DB, Nagelkirk PR, Peckerman A, et al. Exercise and cognitive performance in chronic fatigue syndrome. Med Sci Sports Exerc. 2005;37(9):1460–1467.
  • Weaver SA, Janal MN, Aktan N, et al. Sex differences in plasma prolactin response to tryptophan in chronic fatigue syndrome patients with and without comorbid fibromyalgia. JWomens Health. 2010;3:6–11.
  • Ciccone DS, Natelson BH. Comorbid illness in the chronic fatigue syndrome: a test of the single syndrome hypothesis. PsychosomMed. 2003;62:268–275.
  • Pejovic S, Natelson BH, Basta M, et al. Chronic fatigue syndrome and fibromyalgia in diagnosed sleep disorders: a further test of the ‘unitary’ hypothesis. BMC Neurol. 2015;15:53.
  • White KP, Speechley M, Harth M, et al. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999;26:1570–1576.
  • Kishi A, Struzik ZR, Natelson BH, et al. Dynamics of sleep stage transitions in healthy humans and patients with chronic fatigue syndrome. Am J Physiol Regul Integr Comp Physiol. 2008;294(6):R1980–R1987.
  • Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–610.
  • Kaseeska K, Brown M, Jason LA. Comparing two fibromyalgia diagnostic criteria in a cohort of chronic fatigue syndrome patients. BullIACFS/ME. 2011;19:47–57.